Showing 1971-1980 of 3134 results for "".
- Dual 1550/1927-nm Laser System Shows Favorable Outcomes in Skin of Colorhttps://modernaesthetics.com/news/dual-15501927-nm-laser-system-shows-favorable-outcomes-in-skin-of-color/2485840/Non-ablative fractional laser treatments are widely used for dyschromia, scarring, and photoaging, yet data in patients with skin of color remain comparatively limited. In a review published online in Lasers in Surgery and Medicine, the authors evaluated the safety and efficacy of a dual
- Photocurable Collagen Filler Aims to Address Weight-Loss–Associated Facial Deflationhttps://modernaesthetics.com/news/photocurable-collagen-filler-aims-to-address-weight-lossassociated-facial-deflation/2485851/CollPlant Biotechnologies announced the strategic positioning of its photocurable dermal filler platform to address facial volume loss associated with rapid weight reduction, including in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA) for metabolic health and weight ma
- The Rise of Biostimulators: Complement, Not Competitor, in Aesthetic Regimenshttps://modernaesthetics.com/news/the-rise-of-biostimulators-complement-not-competitor-in-aesthetic-regimens/2485824/The filler category of medical aesthetics may have faced certain headwinds in 2025, but biostimulatory agents experienced a noticeable uptick. Still, at the 2026 Octane Aesthetics Tech Forum, “Flipping the Filler Script” panelists cautioned against viewing them as a replacement for hyaluronic aci
- Octane Aesthetics Tech Forum: Strategy Over Syringes Leads 2025 Filler Reboundhttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-strategy-over-syringes-leads-2025-filler-rebound/2485717/“Flipping the Filler Script” was a hot topic at the 2026 Octane Aesthetics Tech Forum held January 8 and 9 in Newport Beach, California. The panel was moderated by Jason D. Bloom, MD, FACS, of Bloom Facial Plastic Surgery in Bryn Mawr, Pennsylvania, and panelists included Shawna Chrisman, NP, Chi
- Systematic Review Supports Efficacy of Targeted HA Chin Injection Strategyhttps://modernaesthetics.com/news/systematic-review-supports-efficacy-of-targeted-ha-chin-injection-strategy/2485670/Chin augmentation with hyaluronic acid (HA) fillers has become a cornerstone of lower facial contouring. In a systematic review and meta-analysis published online in Aesthetic Plastic Surgery, the authors evaluated the safety and efficacy of a two-three-point injection technique for chin
- Can Injectables and Facelifts Coexist? Early Data Suggest Yeshttps://modernaesthetics.com/news/can-injectables-and-facelifts-coexist-early-data-suggest-yes/2485646/Facelift surgery remains a foundational procedure for facial rejuvenation, but it may not fully correct age-related volume loss, skin quality changes, or dynamic rhytides. As a result, injectables and energy-based devices are frequently incorporated before and after rhytidectomy, despite limited
- A Whole-Face, Whole-Patient Framework Review for Aesthetic Consultationhttps://modernaesthetics.com/news/a-whole-face-whole-patient-framework-review-for-aesthetic-consultation/2485626/Aesthetic facial rejuvenation is increasingly defined by comprehensive, patient-centered assessment rather than isolated correction of individual features, according to a multidisciplinary review published in Dermatologic Surgery. Drawing on insights from dermatology, plastic surgery, an
- New Consensus Algorithm Guides Skincare Use With Energy-Based Acne Treatmentshttps://modernaesthetics.com/news/new-consensus-algorithm-guides-skincare-use-with-energy-based-acne-treatments/2485595/A new consensus-based study published in Journal of Drugs in Dermatology outlines a practical, stepwise algorithm for integrating skincare with energy-based devices (EBDs) in the management of acne and acne sequelae. Titled “Practical Algorithm for Acne Treatment Integrating Skincare
- Octane Aesthetics Tech Forum Panelists React to FDA Approval of Oral Semaglutidehttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-react-to-fda-approval-of-oral-semaglutide/2485572/At the 2026 Octane Aesthetics Tech Forum, panelists weighed in on the recent FDA approval of oral semaglutide, offering a mix of cautious optimism and clinical realism. While the approval marks a milestone in expanding GLP-1 receptor agonist (RA) access, most experts on the panel said oral versio
- Octane Aesthetics Tech Forum: Panelists Discuss Innovation in Hair Loss Delivery, Regulationhttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-panelists-discuss-innovation-in-hair-loss-delivery-regulation/2485561/The future of hair restoration may be rooted in regenerative science, but panelists at the Octane Aesthetics Tech Forum agree: the real-world success of these advances hinges on how treatments are delivered and how they’re regulated. Speaking during the “Hiding in the Shadows of H